Dezhe Medicine is a listed company in science and technology innovation board, and it is an innovation-driven biomedical company with global competitiveness. Therefore, its refinancing has been approved by the Shanghai Stock Exchange, which also shows that the supervision is tolerant of companies with core technology and hard power. Although it may not be ideal financially for the time being, it has broad prospects and great imagination, which is worthy of support.The previous wave of adjustment of the Hang Seng Index was to step back on the long-term trend line at the daily level, which gained support and rebounded recently. Today, it closed above the offensive line, and the long-term trend at the daily level remains intact. On the monthly level, it fell below the offensive line last month, but it is above the offensive line at present, and it closed above 19,738 points this month. The problem is not big, and the long-term trend remains intact, and there is a basis for further strength.The latest progress of stamp duty in Hong Kong has come!
This is a real long-term positive, which is manifested in three aspects: first, it is conducive to attracting investors to invest in the broad-based index through personal pension accounts; Second, it is helpful to inject new long-term funds into the capital market, optimize the investor structure, stabilize the market and promote the healthy development of the capital market; Third, it reflects the care of the regulatory authorities for the capital market and helps to enhance investors' confidence.Statement: Personal opinion, for reference only!Shanghai stock exchange recently released
At present, I am optimistic about tomorrow's trend. It is stronger than expected to maintain this trend today. Although the index has not increased much, the short-term trend at the daily level is still upward, and the quantity can be maintained. Should it continue to rise? The probability of continuing to close up tomorrow is still very high, and the short-term trend of the 60-minute level is to go well again.Dizhe Pharmaceutical announced that the company's private placement plan has been approved by the Shanghai Stock Exchange. This is the first time that the refinancing of the unprofitable enterprise on the Shanghai Stock Exchange has been approved since the release of "Keba Article".Yesterday, the market opened higher and went lower, and the shape looked very poor. Many friends today estimated that they were prepared to continue the downward adjustment, but in fact, the market was still relatively stable today. Although the increase was not large, there was no sharp diving in the plate, as if it were held by a hand. Yes, it is really held up now, because it is now in a state of high control, so everyone has seen the recent trend. Excluding yesterday, it is still relatively stable. How many investors expect the market to fall down and get on the bus, but it just won't come down. The 3150 gap below is counted this week, and it has not been replenished for 11 weeks. It cannot be said that the market is not strong. So can the market continue to rise tomorrow? Let's make a detailed analysis and give you a reference.
Strategy guide
Strategy guide
12-13